about
Activation of NF-kB pathway by virus infection requires Rb expression.Hepatic p63 regulates steatosis via IKKβ/ER stressp130Rb2 and p27kip1 cooperate to control mobilization of angiogenic progenitors from the bone marrow.Female Nur77-deficient mice show increased susceptibility to diet-induced obesity.The central Sirtuin 1/p53 pathway is essential for the orexigenic action of ghrelin.Transcriptional regulation of Sox2 by the retinoblastoma family of pocket proteins.The dependence receptor Ret induces apoptosis in somatotrophs through a Pit-1/p53 pathway, preventing tumor growth.Cooperation between p27 and p107 during endochondral ossification suggests a genetic pathway controlled by p27 and p130.p27(Kip1) directly represses Sox2 during embryonic stem cell differentiation.Of mice without pockets: mouse models to study the function of Rb family proteins.Cyclin-dependent kinase inhibitor p21 controls adult neural stem cell expansion by regulating Sox2 gene expressionCell senescence is an antiviral defense mechanismKSHV latent protein LANA2 inhibits sumo2 modification of p53.SUMOylation regulates AKT1 activity.New scaffolds encapsulating TGF-β3/BMP-7 combinations driving strong chondrogenic differentiation.Transcriptional repression of Bmp2 by p21(Waf1/Cip1) links quiescence to neural stem cell maintenance.Anti-tumor efficacy of chitosan-g-poly(ethylene glycol) nanocapsules containing docetaxel: anti-TMEFF-2 functionalized nanocapsules vs. non-functionalized nanocapsules.Polyaminoacid nanocapsules for drug delivery to the lymphatic system: Effect of the particle size.Highly efficient system to deliver taxanes into tumor cells: docetaxel-loaded chitosan oligomer colloidal carriers.Expression of the human growth hormone normal gene (hGH-N) in proliferating and differentiated HL-60 cells.Conjugation of SUMO to p85 leads to a novel mechanism of PI3K regulation.Selective interaction of PEGylated polyglutamic acid nanocapsules with cancer cells in a 3D model of a metastatic lymph nodeActivation of the double-stranded RNA-dependent protein kinase PKR by small ubiquitin-like modifier (SUMO).Rho activity can alter the translation of p27 mRNA and is important for RasV12-induced transformation in a manner dependent on p27 status.Prothymosin alpha stimulates Ca2+-dependent phosphorylation of elongation factor 2 in cellular extracts.Cyclin A probes by means of intermolecular sensitization of terbium-chelating peptides.Hypochondroplasia and Acanthosis nigricans: a new syndrome due to the p.Lys650Thr mutation in the fibroblast growth factor receptor 3 gene?The cyclin-dependent kinase inhibitor p27 kip1 regulates radial stem cell quiescence and neurogenesis in the adult hippocampus.Ghrelin requires p53 to stimulate lipid storage in fat and liver.p107 Deficiency Increases Energy Expenditure by Inducing Brown-fat Thermogenesis and Browning of White Adipose TissueAdult Sox2+ stem cell exhaustion in mice results in cellular senescence and premature agingDocetaxel-loaded polyglutamic acid-PEG nanocapsules for the treatment of metastatic cancerContext-Dependent Impact of RAS Oncogene Expression on Cellular Reprogramming to PluripotencyComplex regulation of prothymosin alpha in mammary tumors arising arising in transgenic miceTuning the Size of Nanoassembles: A Hierarchical Transfer of Information from Dendrimers to Polyion ComplexesA multifunctional drug nanocarrier for efficient anticancer therapy
P50
Q33489563-1A135834-128B-4623-8FE3-61ABC98ABB26Q33654494-A6EDCCC3-51A0-4080-8DB9-D9E61BC86CEEQ33771424-EDF94639-5492-4C85-82FD-33BD37743E98Q34558800-C67DFCCA-5A19-4936-BF85-E57331395B83Q34718745-721F9E81-34C3-4F51-9CC4-9E2CC15913C1Q35550151-480E5857-E4A8-4936-8312-6BE0A5440273Q35752727-330CEF8B-8560-4C33-9A43-E480035D315BQ35949581-81313AEC-6B7A-478F-B74E-669D6A345F2CQ36546981-1185673E-57EF-4C41-BC0E-45AE86D631E0Q36814044-98EF8341-B8DC-4813-B1EA-63E88F15C779Q37023123-F4592586-681A-43D9-B29A-221B64F3C657Q37416859-DB702907-8211-4B00-856D-E33E3CFA30BFQ38917974-E3022AD3-B016-4E03-9C30-60187D75AC43Q39007397-20126145-06D2-4223-8FA2-427CBAEF164BQ39021292-7D9B6573-D209-4F32-82E4-79DE16CBB7C8Q39085673-188F303D-73F1-4408-9F75-E7F74AD3A64AQ39221855-0A89E5F3-FF5F-4AAE-BC2C-4CF37E059494Q39745826-98929DF5-2904-487A-9A52-009DF78ECA85Q39959738-81C9CD05-F7C0-4D6C-8841-C51B02AD5B13Q41159316-93D81018-76F8-4581-8ABC-8FA17294FABAQ41303929-22FF1916-C067-48DF-BA79-955CDB5F9F7EQ42122391-2844210E-1985-4480-9F0E-9054E0E7AB1FQ42203018-1DC1B992-62CF-4D05-906A-215F16E905C2Q42818079-761976FD-51EA-4ACE-AF18-712EB94A5C72Q42829882-46784B83-CECA-4B9E-B19E-A98595640340Q46508186-ED5796BD-41C3-46C6-98FA-A6C9F55DB1E9Q46516316-EA614245-5A78-403E-8E74-CA758AE7149EQ48566419-8E948830-D8A9-4102-B216-2D500EFF4DDDQ50853236-11BAAD35-3341-4993-A92A-7933FE0B4D0AQ58083624-98EBB625-3F00-471C-807A-50749318FD7CQ58733079-3BA41DE3-5B3B-4D34-8AC8-1B858220BE65Q59342609-FD723EAB-1B0A-4838-80D6-A7BC48EC8132Q64072316-7932893F-DF59-4714-805C-C94AAFF7BF9BQ77893386-C7231BF0-AE56-4431-8371-891D8CE58E04Q88027580-DB2BD729-0EAA-4785-AC79-2B7B1431FD4CQ90359608-5E522497-0315-4508-AD48-FBCC726C4681
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Anxo Vidal
@ast
Anxo Vidal
@en
Anxo Vidal
@es
Anxo Vidal
@nl
type
label
Anxo Vidal
@ast
Anxo Vidal
@en
Anxo Vidal
@es
Anxo Vidal
@nl
prefLabel
Anxo Vidal
@ast
Anxo Vidal
@en
Anxo Vidal
@es
Anxo Vidal
@nl
P106
P1153
7102770115
P31
P496
0000-0002-0866-4202